Healthcare in general and Medical Devices in particular have been very strong lately during the stock market rally. What the device sector also has is a smoother fundamental profile than most sectors during economic soft spots and recessions. Preamble aside, BSX dropped hard on a sales miss that I don’t think is a big deal, beyond the initial knee jerk disappointment of the momo analysts … Continue reading NFTRH+; Opportunity Ahead in This Medical Device Co.
Here are three stocks flying around at new highs. There are probably plenty more and given that the broad market is now pushing the limits, the bears can be forgiven for wincing when they look at pictures like these. Boeing is supposedly economically sensitive. Well, it’s sensing a good economy then. Stryker is a Medical Device company flying around up there. The whole Device sector … Continue reading A Few Stocks At New Highs
I am still pissed that INGN proved me wrong and took my money. I’ll get you… my pretty. An over valued pig if there ever was one. As noted earlier, I sold MDT and took the profit. That was in addition to a dividend already collected. Thank you sir. But speaking of dividends, it occurs to me that many of these pigs are soaked with … Continue reading About Those Over Valued Medical Device Companies
As an example of how I am going about this bubble, my main risk management tool is to make sure I am routinely taking profits in the ones that boom and replanting in the ones that are in setups. For instance, I highlighted Boston Scientific (BSX) for NFTRH+ due to its decline to a weekly moving average that had supported it for the last few … Continue reading Plan in Action, BSX Edition
The simplest NFTRH+ update ever. Boston Scientific is pulling back to the weekly moving average that has held its 4 previous pullbacks. No further comment other than I am watching and considering it but prefer competitor MDT, which I hold, and that any interest here should include personal research, including on the main reason for the pullback, which was a product launch delay. A reminder … Continue reading NFTRH+; Med Device Co. Pullback Opp.
Former NFTRH+ bull stock BSX was recently highlighted as a short due to this disgusting chart. When it was highlighted it was below the SMA 50 but went on to become more bearish in creating and breaking a neckline. At that point a target was assigned. Looking good for anyone who tried this and is still holding. But don’t be greedy. As noted in a … Continue reading NFTRH+; BSX Just About to Target (Public)
I thought the pattern was sneaky bullish and that is why I held BSX as I sold the others last week. Today it boinks the 50 day moving averages.
As noted earlier in the week, MSCC was bought back at support after being sold just below target. So far, so good although also uninspiring as yet.